Clinical Trial Update: Lamivudine for Chronic Hepatitis B [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 trial evaluating lamivudine for chronic hepatitis B. The study also involved related conditions including chroni…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glomerulonephritis
• Hepatitis B
• Hepatitis D
• Polyarteritis Nodosa

Drugs mentioned

• Lamivudine (lamivudine)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Chronic Hepatitis B, Chronic Hepatitis D | Phase 2 | Status: COMPLETED